Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: Effects on corpus luteum function

Richard Stouffer, G. D. Hodgen, A. C. Ottobre, C. D. Christian

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Administration of charcoal-extracted porcine follicular fluid (pFF) to rhesus monkeys at the time of menses impairs the subsequent function of the corpus luteum of the menstrual cycle. The following studies were performed: 1) to characterize the luteal phase defect induced by pFF treatment at menses, and 2) to determine whether pFF treatment in the luteal phase alters corpus luteum function. Adult, female rhesus monkeys were injected sc for 3 days with pFF (10, 5, and 5 ml) beginning on day 1 (n = 5) or day 18 (n = 4) of the menstrual cycle. Femoral venous blood was collected daily throughout the treatment cycle and during the posttreatment cycle of day 18- to 20-treated monkeys. Serum LH, FSH, 17β-estradiol (E2), and progesterone (P) were measured by RIA. After pFF treatment on days 1-3, FSH and E2 levels in the early follicular phase were less (P <0.05) than those of control cycles (n = 7). Serum LH was not suppressed by pFF treatment. Moreover, the preovulatory rise in circulating E2 and the amplitude of LH/FSH surge were similar in control and pFF-treated monkeys. Although timely gonadotropin surges occurred in 4 of 5 pFF-treated monkeys, serum P was markedly reduced (P <0.05) during the first half of the luteal phase. Circulating P increased to control levels during the late luteal phase before normal onset of menses 16.3 ± 1.0 (SE) days after the LH surge. Treatment with pFF on days 18-20 of the cycle reduced the levels of circulating FSH, but serum LH, E2, P, and the length of the luteal phase remained comparable to control cycles. Moreover, the hormonal patterns and the length of the follicular and luteal phases in the posttreatment cycle indicated normal ovarian function. Thus, the pFF treatment at menses results in an aberrant ovarian cycle characterized by an insufficient, rather than short, luteal phase. Whereas pFF treatment in the early follicular phase, vitiates development of the dominant follicle and the related corpus luteum, similar treatment at midluteal phase does not suppress concurrent luteal function or subsequent folliculogenesis.

Original languageEnglish (US)
Pages (from-to)1027-1033
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume58
Issue number6
StatePublished - 1984
Externally publishedYes

Fingerprint

Follicular Fluid
Luteal Phase
Corpus Luteum
Swine
Fluids
Menstruation
Surges (fluid)
Follicular Phase
Menstrual Cycle
Haplorhini
Macaca mulatta
Serum
Charcoal
Level control
Thigh
Gonadotropins
Progesterone
Estradiol
Blood

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle : Effects on corpus luteum function. / Stouffer, Richard; Hodgen, G. D.; Ottobre, A. C.; Christian, C. D.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 58, No. 6, 1984, p. 1027-1033.

Research output: Contribution to journalArticle

@article{53ce84e25a3c40c3a6806853c8d6c12f,
title = "Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: Effects on corpus luteum function",
abstract = "Administration of charcoal-extracted porcine follicular fluid (pFF) to rhesus monkeys at the time of menses impairs the subsequent function of the corpus luteum of the menstrual cycle. The following studies were performed: 1) to characterize the luteal phase defect induced by pFF treatment at menses, and 2) to determine whether pFF treatment in the luteal phase alters corpus luteum function. Adult, female rhesus monkeys were injected sc for 3 days with pFF (10, 5, and 5 ml) beginning on day 1 (n = 5) or day 18 (n = 4) of the menstrual cycle. Femoral venous blood was collected daily throughout the treatment cycle and during the posttreatment cycle of day 18- to 20-treated monkeys. Serum LH, FSH, 17β-estradiol (E2), and progesterone (P) were measured by RIA. After pFF treatment on days 1-3, FSH and E2 levels in the early follicular phase were less (P <0.05) than those of control cycles (n = 7). Serum LH was not suppressed by pFF treatment. Moreover, the preovulatory rise in circulating E2 and the amplitude of LH/FSH surge were similar in control and pFF-treated monkeys. Although timely gonadotropin surges occurred in 4 of 5 pFF-treated monkeys, serum P was markedly reduced (P <0.05) during the first half of the luteal phase. Circulating P increased to control levels during the late luteal phase before normal onset of menses 16.3 ± 1.0 (SE) days after the LH surge. Treatment with pFF on days 18-20 of the cycle reduced the levels of circulating FSH, but serum LH, E2, P, and the length of the luteal phase remained comparable to control cycles. Moreover, the hormonal patterns and the length of the follicular and luteal phases in the posttreatment cycle indicated normal ovarian function. Thus, the pFF treatment at menses results in an aberrant ovarian cycle characterized by an insufficient, rather than short, luteal phase. Whereas pFF treatment in the early follicular phase, vitiates development of the dominant follicle and the related corpus luteum, similar treatment at midluteal phase does not suppress concurrent luteal function or subsequent folliculogenesis.",
author = "Richard Stouffer and Hodgen, {G. D.} and Ottobre, {A. C.} and Christian, {C. D.}",
year = "1984",
language = "English (US)",
volume = "58",
pages = "1027--1033",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle

T2 - Effects on corpus luteum function

AU - Stouffer, Richard

AU - Hodgen, G. D.

AU - Ottobre, A. C.

AU - Christian, C. D.

PY - 1984

Y1 - 1984

N2 - Administration of charcoal-extracted porcine follicular fluid (pFF) to rhesus monkeys at the time of menses impairs the subsequent function of the corpus luteum of the menstrual cycle. The following studies were performed: 1) to characterize the luteal phase defect induced by pFF treatment at menses, and 2) to determine whether pFF treatment in the luteal phase alters corpus luteum function. Adult, female rhesus monkeys were injected sc for 3 days with pFF (10, 5, and 5 ml) beginning on day 1 (n = 5) or day 18 (n = 4) of the menstrual cycle. Femoral venous blood was collected daily throughout the treatment cycle and during the posttreatment cycle of day 18- to 20-treated monkeys. Serum LH, FSH, 17β-estradiol (E2), and progesterone (P) were measured by RIA. After pFF treatment on days 1-3, FSH and E2 levels in the early follicular phase were less (P <0.05) than those of control cycles (n = 7). Serum LH was not suppressed by pFF treatment. Moreover, the preovulatory rise in circulating E2 and the amplitude of LH/FSH surge were similar in control and pFF-treated monkeys. Although timely gonadotropin surges occurred in 4 of 5 pFF-treated monkeys, serum P was markedly reduced (P <0.05) during the first half of the luteal phase. Circulating P increased to control levels during the late luteal phase before normal onset of menses 16.3 ± 1.0 (SE) days after the LH surge. Treatment with pFF on days 18-20 of the cycle reduced the levels of circulating FSH, but serum LH, E2, P, and the length of the luteal phase remained comparable to control cycles. Moreover, the hormonal patterns and the length of the follicular and luteal phases in the posttreatment cycle indicated normal ovarian function. Thus, the pFF treatment at menses results in an aberrant ovarian cycle characterized by an insufficient, rather than short, luteal phase. Whereas pFF treatment in the early follicular phase, vitiates development of the dominant follicle and the related corpus luteum, similar treatment at midluteal phase does not suppress concurrent luteal function or subsequent folliculogenesis.

AB - Administration of charcoal-extracted porcine follicular fluid (pFF) to rhesus monkeys at the time of menses impairs the subsequent function of the corpus luteum of the menstrual cycle. The following studies were performed: 1) to characterize the luteal phase defect induced by pFF treatment at menses, and 2) to determine whether pFF treatment in the luteal phase alters corpus luteum function. Adult, female rhesus monkeys were injected sc for 3 days with pFF (10, 5, and 5 ml) beginning on day 1 (n = 5) or day 18 (n = 4) of the menstrual cycle. Femoral venous blood was collected daily throughout the treatment cycle and during the posttreatment cycle of day 18- to 20-treated monkeys. Serum LH, FSH, 17β-estradiol (E2), and progesterone (P) were measured by RIA. After pFF treatment on days 1-3, FSH and E2 levels in the early follicular phase were less (P <0.05) than those of control cycles (n = 7). Serum LH was not suppressed by pFF treatment. Moreover, the preovulatory rise in circulating E2 and the amplitude of LH/FSH surge were similar in control and pFF-treated monkeys. Although timely gonadotropin surges occurred in 4 of 5 pFF-treated monkeys, serum P was markedly reduced (P <0.05) during the first half of the luteal phase. Circulating P increased to control levels during the late luteal phase before normal onset of menses 16.3 ± 1.0 (SE) days after the LH surge. Treatment with pFF on days 18-20 of the cycle reduced the levels of circulating FSH, but serum LH, E2, P, and the length of the luteal phase remained comparable to control cycles. Moreover, the hormonal patterns and the length of the follicular and luteal phases in the posttreatment cycle indicated normal ovarian function. Thus, the pFF treatment at menses results in an aberrant ovarian cycle characterized by an insufficient, rather than short, luteal phase. Whereas pFF treatment in the early follicular phase, vitiates development of the dominant follicle and the related corpus luteum, similar treatment at midluteal phase does not suppress concurrent luteal function or subsequent folliculogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0021253390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021253390&partnerID=8YFLogxK

M3 - Article

C2 - 6427256

AN - SCOPUS:0021253390

VL - 58

SP - 1027

EP - 1033

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 6

ER -